Searched for
FOSUN HEALTHCARE
Brookfield, EQT close in on Gland Pharma, but rising stock a painThe Chinese parent has diversified investments that range from healthcare to football clubs, asset management, banks, estate, hospitality, ...- Private equity owners pull Medall Healthcare out of insolvencyThe National Company Law Tribunal had admitted Medall Healthcare for insolvency proceedings on May 2 after a creditor of the company approa...
- China’s Fosun pulls out of $300 million healthcare deals amid negative sentimentAccording to sources, both deals were at an advanced stage, and Fosun had formally proposed terms for acquiring a stake in the companies, o...
- China’s Fosun International group in talks to acquire Medall HealthcareUS firm Constellation Alpha had earlier agreed to buy the Indian diagnostic chain, but deal fell through.
- IHH Healthcare submits fresh bid for FortisIHH today issued a letter to the board of Fortis "setting out a binding offer, which supersedes and replaces the enhanced revised proposal,...
- Fortis subsidiary directed to pay Rs 503 cr to DGHS within a monthFortis said Escort Heart Institute & Research Centre had received an order dated June 9, 2016, from Directorate General of Health Services ...
- Fortis: Sebi probes insider trading violation, other regulatory lapsesFortis is in the midst of a heated takeover battle with five entities bidding for the company.
- Review all bids: Yes Bank to FortisThis is the first time a key shareholder has decided not to take the Munjal-Burman offer as the final one. The fate of 4 board members of F...
- Race for Fortis: IHH may file binding offer before April 25IHH has already submitted its non-binding expression of interest to the board at a valuation of Rs 160 per share, offering to infuse Rs 4,0...
- Munjals, Burmans extend validity of their offer for FortisThe development follows the Fortis board forming an expert panel last week to evaluate binding offers and make the final recommendation by ...
- China’s Fosun emerges as the fourth contender for cash-strapped Fortis healthcareChina's Fosun has assets of $75 billion and an existing investment in India’s Gland Pharma, which it purchased from US buyout giant KKR.
- Fosun targets Fortis: A white knight or a dark horse?Often known as China's Warren Buffett, Guo Guangchang prefers to be his student instead. His mysterious disappearance last year raised many...
- Stocks in focus on April 18, 2018Here is a list of top stocks that are likely to be in focus in today's trading session.
- Fosun may invest in 2 to 3 Indian startups by year endThe venture firm is actively hunting for startups in the logistics and fintech space to invest in early-stage opportunities.
- Chinese conglomerate Fosun International to make its first investment in India in IxigoThis would be the first venture transaction by Fosun International in India after setting shop in the country almost a year ago
- Fosun agrees to buy KKR-backed Gland Pharma for $1.4 billion: SourceThe deal would be the first major move by the Fosun group since Guo Guangchang, founder of flagship holding firm Fosun International Ltd an...
- China's Shanghai Fosun to acquire 86% stake in Gland Pharma for $1.4 billionShanghai Fosun will acquire the shares held by Gland Pharma founders Ravi Penmetsa and his family and PE giant KKR.
- China's Fosun to buy KKR backed Gland Pharma for $1.4 billionFosun has agreed to acquire 96 percent stake, which includes shares held by founders of Gland Pharma Ravi Penmetsa and family and private e...
- Fosun leads the race to buy Gland Pharma with $1.27 billion bidComing from behind in a closely fought race that saw US giant Baxter and private equity fund Advent make firm offers early May, Hong Kong-l...
- China’s search engine Baidu, conglomerate Fosun scouting to invest in Indian startupsBaidu is China’s most popular search engine. The company is listed on Nasdaq and has a market cap of $52 bn. Fosun is listed in Hong Kong.
Load More
